SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-010261
Filing Date
2022-06-24
Accepted
2022-06-24 15:56:14
Documents
12
Period of Report
2022-06-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20220623x8k.htm   iXBRL 8-K 34118
  Complete submission text file 0001558370-22-010261.txt   151870

Data Files

Seq Description Document Type Size
2 EX-101.SCH ampe-20220623.xsd EX-101.SCH 3286
3 EX-101.LAB ampe-20220623_lab.xml EX-101.LAB 15367
4 EX-101.PRE ampe-20220623_pre.xml EX-101.PRE 10382
6 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20220623x8k_htm.xml XML 4676
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 221039920
SIC: 2834 Pharmaceutical Preparations